Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2025

Mar 5, 2025

33625_dirs_2025-03-04_97151162-70cd-47a6-aa74-20632ab231c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2025-02-28

Reporting Person: Smith Kevin P. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-01 Common Stock A 1186 $8.33 Acquired 1186 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-28 Restricted Stock Unit $ A 42016 Acquired Common Stock (42016) Direct

Footnotes

F1: Shares acquired through the Company's 2014 Employee Stock Purchase Plan.

F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.